Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The DENIVOS study page shows only minor administrative edits, including formatting tweaks and an updated timestamp. There are no changes to core trial details, eligibility criteria, or the list of participating sites. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:16:31.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    - Added a government funding notice and open status details (affects trust and usage guidance). - Updated version from v3.1.0 to v3.2.0 and removed the old version reference.
    Difference
    3%
    Check dated 2025-10-06T04:14:34.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:38:56.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element was removed; no changes to pricing, stock, or time slot availability.
    Difference
    0.2%
    Check dated 2025-09-14T09:54:34.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T07:48:03.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while removing extensive drug-related information and previous location terms.
    Difference
    3%
    Check dated 2025-08-31T00:56:28.000Z thumbnail image

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.